v3.25.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
REVENUE $ 43   $ 12 $ 108 $ 498
OPERATING EXPENSES          
Research and development expenses 312   289 1,954 741
Selling and marketing expenses 208   249 1,201 639
General and administration expenses 1,588   565 6,133 2,196
Impairment of intangible assets 874 $ 874   874 0
TOTAL OPERATING EXPENSES 2,108   1,103 10,162 3,576
OPERATING LOSS (2,065)   (1,091) (10,054) (3,078)
OTHER INCOME (EXPENSE)          
Interest and bank fees (128)   (2) (69) (18)
Unrealized gain (loss) on foreign exchange 3   (28) 11 37
Change in derivative fair value (9,369)   0 (156) 0
Other income (expense) (18)   (1) (190) 457
TOTAL OTHER INCOME (EXPENSE) (10,865)   (31) (404) 476
LOSS BEFORE INCOME TAX (12,930)   (1,122) (10,458) (2,602)
Income tax provision 0   0 (2) (1)
NET LOSS AND COMPREHENSIVE LOSS $ (12,930)   $ (1,122) $ (10,460) $ (2,603)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (1.74)   $ (0.22) $ (1.6) $ (0.81)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING, BASIC AND DILUTED (in shares) 9,956,933   5,194,665 6,546,769 3,233,270